Clinical Trial Update: Impact of CYP3A5 Gene Polymorphisms on Tacrolimus Concentrations and Outcomes in Thai Transplant Recipients

View source ↗

Summary

A clinical trial update examining how CYP3A5 gene variants affect tacrolimus blood levels and outcomes in Thai kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Mahidol University | Conditions: Kidney Transplant | Status: UNKNOWN